In 1974, Congress passed the Safe Drinking Water Act. This law requires EPA to determine the level of contaminants in drinking water at which no adverse health effects are likely to occur. These non-enforceable health goals, based solely on possible health risks and exposure over a lifetime with an adequate margin of safety, are called maximum contaminant level goals (MCLG). Contaminants are any physical, chemical, biological or radiological substances or matter in water.
The MCLG for di(2-ethylhexyl) adipate is 0.4 mg/L or 400 ppb. EPA has set this level of protection based on the best available science to prevent potential health problems. EPA has set an enforceable regulation for di(2-ethylhexyl) adipate, called a maximum contaminant level (MCL), at 0.4 mg/L or 400 ppb. MCLs are set as close to the health goals as possible, considering cost, benefits and the ability of public water systems to detect and remove contaminants using suitable treatment technologies. In this case, the MCL equals the MCLG, because analytical methods or treatment technology do not pose any limitation.
The Phase V Rule, the regulation for di(2-ethylhexyl) adipate, became effective in 1994. The Safe Drinking Water Act requires EPA to periodically review the national primary drinking water regulation for each contaminant and revise the regulation, if appropriate. EPA reviewed di(2-ethylhexyl) adipate as part of the Six Year Review and determined that the 0.4 mg/L or 400 ppb MCLG and 0.4 mg/L or 400 ppb MCL for di(2-ethylhexyl) adipate are still protective of human health.
States may set more stringent drinking water MCLGs and MCLs for di(2-ethylhexyl) adipate than EPA.